Mary Theresa Coelho - 22 Jul 2025 Form 4 Insider Report for HOOKIPA Pharma Inc. (HOOK)

Reporting relationship: EVP and CFO, Director
Issuer ticker: HOOK
Reported as of: 22 Jul 2025
Net transaction value: -$12,520
SEC form: 4
Accepted by SEC: 23 Jul 2025, 18:07:41 UTC
Prior SEC filing: 02 Apr 2025
Next SEC filing: 20 Jul 2026
Source filing: View source filing
Reporting owner signature: /s/ Mary Theresa Coelho

Key filing fact

Mary Theresa Coelho filed Form 4 for HOOKIPA Pharma Inc. (HOOK) on 23 Jul 2025.

Key facts

This page summarizes Mary Theresa Coelho's Form 4 filing for HOOKIPA Pharma Inc. (HOOK).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 23 Jul 2025, 18:07.

Change

Previous filing in this sequence was filed on 02 Apr 2025.
Current net transaction value: -$12,520.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001720772 Primary reporting owner

Coelho Mary Theresa

Relationship: EVP and CFO, Director
Address: C/O HOOKIPA PHARMA INC., 350 FIFTH AVENUE, 72ND FLOOR, SUITE 7240, NEW YORK
Signature: /s/ Mary Theresa Coelho
Signature date: 23 Jul 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

HOOK transaction

Common Stock

Sale

Transaction value: $12,520
Shares: -13,609
Change %: -19%
Price: $0.9200
Shares after: 56,266
Date: 22 Jul 2025
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

This sale was affected pursuant to a "sell to cover" arrangement adopted by the Issuer to satisfy the tax withholding obligations triggered by the vesting of restricted stock units granted on July 22, 2024 and does not represent a discretionary trade by the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer.